Combination Low-Dose Pilocarpine/Diclofenac Sodium and Pilocarpine Alone for Presbyopia: Results of a Randomized Phase 2b Clinical Trial.

In the PP population, the proportion of participants achieving a ≥2-line improvement in DCNVA from baseline on day 8 approached significance only at 1-hour post-treatment with Pilo 0.2% (P < 0.10) and at 20 minutes (P < 0.10) post-treatment with Pilo 0.2%-FDC.

also in 8,237 other papers